|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0008976,
umls-concept:C0011900,
umls-concept:C0023418,
umls-concept:C0026565,
umls-concept:C0026764,
umls-concept:C0030705,
umls-concept:C0035168,
umls-concept:C0041700,
umls-concept:C0043227,
umls-concept:C0936012,
umls-concept:C1518904,
umls-concept:C1521975,
umls-concept:C1551807,
umls-concept:C1556038,
umls-concept:C1563350,
umls-concept:C1563351
|
|
pubmed:issue |
36
|
|
pubmed:dateCreated |
2005-12-19
|
|
pubmed:abstractText |
Early mortality in multiple myeloma (MM) is usually attributed to combined effects of active disease and comorbid factors. We have studied early deaths in a series of large multicenter trials to assess direct causes of death, their predictability, and whether current management strategies have reduced their frequency.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
9219-26
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16275935-Age Factors,
pubmed-meshheading:16275935-Aged,
pubmed-meshheading:16275935-Comorbidity,
pubmed-meshheading:16275935-Female,
pubmed-meshheading:16275935-Humans,
pubmed-meshheading:16275935-Infection,
pubmed-meshheading:16275935-Logistic Models,
pubmed-meshheading:16275935-Male,
pubmed-meshheading:16275935-Middle Aged,
pubmed-meshheading:16275935-Multiple Myeloma,
pubmed-meshheading:16275935-Neoplasm Staging,
pubmed-meshheading:16275935-Prognosis,
pubmed-meshheading:16275935-Renal Insufficiency,
pubmed-meshheading:16275935-Retrospective Studies,
pubmed-meshheading:16275935-Sensitivity and Specificity
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party.
|
|
pubmed:affiliation |
Department of Immunology and Cancer Research United Kingdom Clinical Trials Unit, the University of Birmingham, Birmingham, United Kingdom.
|
|
pubmed:publicationType |
Journal Article
|
